FVC

1 stories · following the connections

Business

FibroGen Announces Publication of Phase 2 Study Results Supporting the Potential of FG-3019 to Treat Patients With Idiopathic Pulmonary Fibrosis

By Nasdaq OMXMar 11, 2016, 1:00 PM UTC